YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FBYLX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,889
Award facts
- Contract value 100% obligated
- $1,888.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,888.62 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) one-dose vials. The delivery order, issued on January 14, 2026, carries an ultimate completion date of February 5, 2026, and was not issued under a set-aside designation. DMS Pharmaceutical Group will perform the work at its headquarters location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide pharmaceutical products and medical consumables to Department of Defense military healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 through December 31, 2036, authorizes the Defense Logistics Agency to issue firm fixed-price orders for branded and generic prescription drugs, biologics, vaccines, and other medical supplies. DMS Pharmaceutical Group's selection as a regional prime vendor contractor reflects the company's demonstrated capability to supply the diverse pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBYLX?
SPE2DR26FBYLX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FBYLX worth?
The government has obligated $1,889 on SPE2DR26FBYLX.
Is contract SPE2DR26FBYLX an order under another contract?
Yes. SPE2DR26FBYLX is a delivery order under SPE2DR25D9103, an indefinite delivery contract.
Was contract SPE2DR26FBYLX competed?
The extent of competition for SPE2DR26FBYLX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award